J Physiol Pharmacol. 2006 Nov;57 Suppl 9:23-33.

Clinical usefulness of probiotics in inflammatory bowel diseases.

Source

Department of Gastroenterology, Hepatology and Infectious Diseases, Jagiellonian University Medical College, Krakow, Poland. tmach@su.krakow.pl

Abstract

Probiotics are live nonpathogenic bacteria or bacterial components that may be helpful in the prevention and treatment of acute diarrhoea in adults and children and have some effects on the course of inflammatory bowel diseases (IBD). Many experimental and clinical studies suggest that intestinal bacterial flora plays an important role in the pathogenesis of IBD, and manipulation of the luminal contents with antibiotics or probiotics represents a potentially effective therapeutic option. The beneficial effect of probiotics was demonstrated mainly in the prevention and treatment of pouchitis and in maintaining remission of mild to moderate ulcerative colitis. Probiotics seems to be less effective in patients with Crohn's disease. Randomized clinical trials are still required to further define the role of probiotics as preventive and therapeutic agents. This review summarizes the current data about probiotics in IBD.

PMID:: 17242485; [PubMed - indexed for MEDLINE]

Free full text

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Supplemental Content

Related citations

Review Antibiotics and probiotics in treatment of inflammatory bowel disease. [World J Gastroenterol. 2006]
Review Antibiotics and probiotics in treatment of inflammatory bowel disease.
Gionchetti P, Rizzello F, Lammers KM, Morselli C, Sollazzi L, Davies S, Tambasco R, Calabrese C, Campieri M. World J Gastroenterol. 2006 Jun 7; 12(21):3306-13.
Review Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. [Proc Nutr Soc. 2007]
Review Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
Hedin C, Whelan K, Lindsay JO. Proc Nutr Soc. 2007 Aug; 66(3):307-15.
Review [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management]. [Tunis Med. 2005]
Review [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
Belkahla N, Maamouri N, Ouerghi H, Ben Ammar A. Tunis Med. 2005 Mar; 83(3):132-6.
Review Clinical utility of probiotics in inflammatory bowel disease. [Altern Ther Health Med. 2011]
Review Clinical utility of probiotics in inflammatory bowel disease.
Cain AM, Karpa KD. Altern Ther Health Med. 2011 Jan-Feb; 17(1):72-9.
Review Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics. [Rev Recent Clin Trials. 2008]
Review Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.
Heilpern D, Szilagyi A. Rev Recent Clin Trials. 2008 Sep; 3(3):167-84.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Clinical usefulness of probiotics in inflammatory bowel diseases.
Clinical usefulness of probiotics in inflammatory bowel diseases.
J Physiol Pharmacol. 2006 Nov ;57 Suppl 9:23-33.

PubMed
Loss of the apical V-ATPase a-subunit VHA-6 prevents acidification of the intest...
Loss of the apical V-ATPase a-subunit VHA-6 prevents acidification of the intestinal lumen during a rhythmic behavior in C. elegans.
Am J Physiol Cell Physiol. 2009 Nov ;297(5):C1071-81. Epub 2009 Sep 9 .

PubMed
Significant longevity-extending effects of EGCG on Caenorhabditis elegans under ...
Significant longevity-extending effects of EGCG on Caenorhabditis elegans under stress.
Free Radic Biol Med. 2009 Feb 1 ;46(3):414-21. Epub 2008 Nov 5 .

PubMed
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role ...
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.
Clin Sci (Lond). 2005 Sep ;109(3):227-41.

PubMed
Sphingosine-1 phosphate: a new player in osteoimmunology.
Sphingosine-1 phosphate: a new player in osteoimmunology.
Dev Cell. 2009 Mar ;16(3):323-4.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Clinical usefulness of probiotics in inflammatory bowel diseases.

Source

Abstract

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Related citations

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information